参考文献/References:
[1] Simonneau G, Gatzoulis MA, Adatia I,et al. Updated clinical classification of pulmonary hypertension[J].J Am Coll Cardiol,2013,62(25 Suppl):D34-D41.
[2] Pepke-Zaba J,Delcroix M,Lang I,et al.Chronic Thromboembolic Pulmonary Hypertension(CTEPH):results from an international prospective registry[J].Circulation,2011,124(18):1973-1981.
[3] Condliffe R,Kiely DG,Gibbs JS,et al.Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension[J].Am J Respir Crit Care Med,2008,177(10):1122-1127.
[4] Kirson NY,Birnbaum HG,Ivanova JI,et al.Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States[J].Curr Med Res Opin,2011,27(9):1763-1768.
[5] Escribano-Subias P,Blanco I,Lopez-Meseguer M,et al.Survival in pulmonary hypertension in Spain:insights from the Spanish registry[J].Eur Respir J,2012,40(3):596-603.
[6] Piazza G,Goldhaber SZ.Chronic thromboembolic pulmonary hypertension[J].N Engl J Med,2011,364(4):351-360.
[7] 韩新鹏,陈佩,马文瑞,等.慢性血栓栓塞性肺动脉高压的流行病学研究[J].中国呼吸与危重监护杂志,2013,12(4):379-383.
[8] Galie N,Kim NH.Pulmonary microvascular disease in chronic thromboembolic pulmonary hypertension[J].Proc Am Thorac Soc,2006,3(7):571-576.
[9] 阮英茆.常见不同类型肺血管病病理学及从病理资料看临床存在的问题[J].心电与循环,2014,33(6):439-441.
[10] Berger G,Azzam ZS,Hardak E,et al.Idiopathic pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension:can we be certain?[J].Isr Med Assoc J,2011,13(2):106-110.
[11] Scheidl SJ,Englisch C,Kovacs G,et al.Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients[J].Eur Respir J,2012,39(1):119-124.
[12] Jaff MR, McMurtry MS,Archer SL,et al. Management of massive and submassive pulmonary embolism, lliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension:a scientific statement from the American Heart Association[J].Circulation,2011,123(16):1788-1830.
[13] Korkmaz A,Ozlu T,Ozsu S,et al.Long-term outcomes in acute pulmonary thromboembolism:the incidence of chronic thromboembolic pulmonary hypertension and associated risk factors[J]. Clin Appl Thromb Hemost,2012,18(3):281-288.
[14] 翟振国,杨媛华,王军,等.急性肺血栓栓塞症与慢性血栓栓塞性肺动脉高压的自然病程[J].中华结核和呼吸杂志,2009, 32(2):141-143.
[15] Mercier O,Fadel E.Chronic thromboembolic pulmonary hypertension:animal models[J].Eur Respir J,2013,41(5):1200-1206.
[16] Delcroix M,Vonk-Noordegraaf A,Fadel E,et al.Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension[J].Eur Respir J,2013,41(1):224-232.
[17] Lang IM.Chronic thromboembolic pulmonary hypertension—not so rare after all[J]. N Engl J Med,2004,350(22): 2236-2238.
[18] Auger WR,Kin NH,Trow TK.Chronic thromboembolic pulmonary hypertension [J].Clin Chest Med,2010,31(4):741-758.
[19] Klok FA,Surie S,Kempf T,et al.A simple non-invasive diagnostic algorithm for ruling out chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism[J].Thromb Res,2011,128(1):21-26.
[20] He J,Fang W,Lv B,et al.Diagnosis of chronic thromboembolic pulmonary hypertension:comparison of ventilation/perfusion scanning and multidetector computed tomography pulmonary angiography with pulmonary angiography[J].Nucl Med Commun,2012,33(5):459-532.
[21] Hoey ET,Mirsadraee S,Pepek-Zaba J,et al.Dual-energy CT angiography for assessment of regional pulmonary perfusion in patients with chronic thromboembolic pulmonary hypertension:initial experience[J].Am J Roentgenol,2011,196(3): 524-532.
[22] Auger WR,Channick RN,Kerr KM,et al.Evaluation of patients with suspected chronic thromboembolic pulmonary hypertension[J].Semin Thorac Cardiovasc Surg,1999,11(2):179-190.
[23] Hoeper MM,Bogaard HJ,Condliffe R,et al.Definitions and diagnosis of pulmonary hypertension[J].J Am Coll Cardiol,2013,62(25 Suppl):D42-D50.
[24] Konstantinides SV,Torbicki A, Agnelli G, et al.2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism[J].Eur Heart J,2014,35(43):3033-3069.
[25] Skoro-Sajer N,Bonderman D,Wiesbauer F,et al.Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension[J].J Thromb Haemost,2007,5(3):483-489.
[26] Nishimura R,Tanabe N,Sugiura T,et al.Improved Survival in Medically Treated Chronic Thromboembolic Pulmonary Hypertension[J].Circ J,2013,77(8):2110-2117.
[27] Ghofrani HA, D'Armini AM, Grimminger F, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension[J].N Engl J Med,2013,369(4):319-329.
[28] Jaïs X, D'Armini AM, Jansa P,et al. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT(Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial[J].J Am Coll Cardiol,2008,52(25):2127-2134.
[29] Feinstein JA, Goldhaber SZ, Lock JE,et al.Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension[J].Circulation,2001,103(1):10-13.
[30] Sugimura K, Fukumoto Y, Satoh K,et al.Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension[J].Circ J,2012,76(2):485-488.
[31] Mizoguchi H, Ogawa A, Munemasa M,et al.Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension[J].Circ Cardiovasc Interv,2012,5(6):748-755.
[32] Madani MM,Auger WR,Pretorius V,et al.Pulmonary endarterectomy:recent changes in a single institution's experience of more than 2 700 patients[J].Ann Thorac Surg,2012,94(1):97-103.
[33] Riedel M,Stanek V,Widimsky J,et al.Long-term follow-up of patients with pulmonary thromboembolism.Late prognosis and evolution of hemodynamic and respiratory data[J].Chest,1982,81(2):151-158.
[34] Saouti N, de Man F, Westerhof N, et al. Predictors of mortality in inoperable chronic thromboembolic pulmonary hypertension[J].Respir Med,2009,103(7):1013-1019.
[35] Mayer E,Jenkins D,Lindner J,et al.Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension:results from an international prospective registry[J].J Thorac Cardiovasc Surg,2011,141(3):702-710.
相似文献/References:
[1]赵靖华,综述,尚美生,等.衰老与心律失常[J].心血管病学进展,2016,(2):121.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.006]
ZHAO Jinghua,SHANG Meisheng,YAO Yan.Aging and Arrhythmias[J].Advances in Cardiovascular Diseases,2016,(3):121.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.006]
[2]查凤艳,综述,覃数,等.心源性恶病质发病机制的研究进展[J].心血管病学进展,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
ZHA Fengyan,QIN Shu.Advances in Pathogenesis of Cardiac Cachexia[J].Advances in Cardiovascular Diseases,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
[3]范贵娟,综述,徐瑞,等.盐敏感性高血压的研究进展[J].心血管病学进展,2016,(4):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
FAN Guijuan,XU Rui.Research Progress of Salt Sensitive Hypertension[J].Advances in Cardiovascular Diseases,2016,(3):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
[4]翟恒博,综述,刘俊,等.缺血性心脏病再认识[J].心血管病学进展,2016,(4):395.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.018]
ZHAI Hengbo,LIU Jun.Rethinking of Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2016,(3):395.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.018]
[5]王静娜,侯瑞田,史亦男,等.糖尿病心肌病发病机制及病理改变研究进展[J].心血管病学进展,2016,(4):412.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.022]
WANG Jingna,HOU Ruitian,SHI Yinan,et al.Research Progress on Pathogenesis and Pathological Changes
of Diabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2016,(3):412.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.022]
[6]钟冬祥 管丽华 周达新.经皮肺动脉成形术在慢性血栓栓塞性肺动脉高压应用中的研究进展[J].心血管病学进展,2019,(5):693.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.008]
ZHONG Dongxiang,GUAN Lihua,ZHOU Daxin.Percutaneous Transluminal Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2019,(3):693.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.008]
[7]秦莉 张艺文 杨晓倩 王燕凤 汪汉.系统性红斑狼疮合并心力衰竭的发病机制及病因[J].心血管病学进展,2020,(4):381.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.013]
QIN Li,ZHANG Yiwen,YANG Xiaoqian,et al.The Pathogenesis and Etiology of Heart Failure in Systemic lupus Erythematosus[J].Advances in Cardiovascular Diseases,2020,(3):381.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.013]
[8]王高峰 管丽华 周达新.慢性血栓栓塞性肺动脉高压新治疗方法的进展[J].心血管病学进展,2022,(1):14.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.004]
WANG Gaofeng,GUAN Lihua,ZHOU Daxin.Chronic Thromboembolic Pulmonary HypertensionEvolving Therapeutic Approaches[J].Advances in Cardiovascular Diseases,2022,(3):14.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.004]
[9]胡美曦 黄志华 柳志红 赵智慧 罗勤 赵青.慢性血栓栓塞性肺动脉高压：构建动物模型的研究进展[J].心血管病学进展,2022,(3):236.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
HU Meixi,HUANG Zhihua,LIU Zhihong,et al.Chronic Thromboembolic Pulmonary Hypertension: Advances in Constructing Animal Models[J].Advances in Cardiovascular Diseases,2022,(3):236.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]